Demsa

What Demsa does

Demsa (legal entity Distribución Especializada de Medicamentos, S.A. de C.V.), operating as Farmacias Demsa, is a privately held Mexican specialty pharmaceutical distributor and pharmacy retailer founded in April 1994 in Monterrey, Nuevo León. The company focuses on high-specialty medications across more than 14 therapeutic areas, including cardiology, endocrinology, oncology, neurology, hematology, immunology, and vaccines, alongside general over-the-counter categories such as analgesics, dermatology, cold/cough remedies, vitamins, and supplements. Distribution extends to temperature-sensitive biologics and injectables such as GLP-1 agonists (Mounjaro/Tirzepatide) and growth hormones (Omnitrope/Somatropin), with documented cold-chain handling and Monday-to-Wednesday shipping windows for out-of-town cold-chain orders.

The company operates two primary channels: a nationwide network of 12 physical pharmacies (including 24-hour locations in Guadalajara and Saltillo) plus three distribution warehouses, and a direct-to-consumer e-commerce platform at demsaenlinea.mx. The online platform supports prescription upload with collection of physician name and professional license number, ZIP-code-based local inventory display, secure checkout, WhatsApp-based stock inquiry integration, and home delivery with free shipping on orders above $1,500 MXN locally. Demsa also offers formal pharmacovigilance reporting and runs manufacturer-branded patient adherence programs (Programas de Apego) with Novartis, Roche, Sanofi, UCB, Lilly, Merck, Pfizer, Amgen, and Organon.

Demsa generates revenue through unit-priced pharmaceutical product sales across both retail and distribution channels. The company holds ISO 9001:2015 certification covering pharmaceutical distribution and customer service operations, and operates a separate supplier portal (demsa.zapto.org/proveedores). It maintains an active recruitment channel and dedicated pharmacovigilance contact, supporting both operational scale and regulatory compliance obligations. No external investment, parent company, or M&A activity is disclosed in the source material.

Name

Demsa

Legal name

Distribución Especializada de Medicamentos, S.A. de C.V.

Website

https://demsaenlinea.mx

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

Demsa (Farmacias Demsa) is a privately held Mexican specialty pharmaceutical distributor and pharmacy retailer operating 12 pharmacies and 3 warehouses nationwide, plus the demsaenlinea.mx e-commerce platform, serving individual patients and partnering with major pharma manufacturers on adherence programs.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Distribution

NAICS

Pharmacies and Drug Retailers (456110), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ)

akta.pro secondary industries

Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

Keywords

• Specialty pharmacy distribution
• High-specialty medications
• Cold chain logistics
• Prescription fulfillment
• Pharmaceutical e-commerce

Headquarters

HQ city

San Pedro

HQ country

Mexico

HQ region

Latin America

Offices15 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Revenue is generated through the sale of both prescription and non-prescription medications across multiple therapeutic categories including cardiology, endocrinology, oncology, neurology, and general medicine. Products are sold through physical pharmacies and the online platform.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Demsa distributes and dispenses prescription and OTC medications across 15+ therapeutic categories through 12 physical pharmacies, 3 distribution warehouses, and a nationwide e-commerce platform. Its core specialty is the storage and dispensing of high-specialty cold-chain medications for chronic and complex conditions, supported by co-managed patient adherence programs with major pharmaceutical manufacturers.

Product overview

Demsa operates as a specialized pharmaceutical distribution company and online pharmacy platform serving Mexico. The company offers a dual offering: (1) an e-commerce pharmacy platform enabling prescription medication purchases with home delivery nationwide, and (2) a network of 12 physical pharmacies and 3 distribution warehouses across Mexico. Product categories span general over-the-counter medications (analgesics, stomach remedies, dermatology, cold/cough, vitamins) and high-specialty medications across 14+ therapeutic areas including Cardiology, Endocrinology, Oncology, Hematology, Neurology, and Vaccines. Specialty medications include injectable GLP-1 agonists (MOUNJARO/Tirzepatide), growth hormones (OMNITROPE/Somatropin), and oncology treatments. The company maintains cold chain distribution capabilities and offers patient adherence programs in partnership with major pharmaceutical manufacturers. Digital services include prescription upload, WhatsApp-based customer support, and pharmacovigilance reporting.

Differentiator

Problem solved

Functional benefit

Products and services

• Prescription and OTC medication dispensing Dispensing of prescription and OTC medications across 15+ therapeutic categories through 12 physical pharmacies and a nationwide e-commerce platform, targeted at individual patients in Mexico.
• High-specialty (cold chain) medications Storage and dispensing of high-specialty medications requiring cold-chain handling, primarily for chronic, complex, and orphan-indication conditions.
• Manufacturer co-managed adherence programs (Programas de Apego) Patient adherence and support programs co-managed with major pharmaceutical manufacturers, designed to improve persistence and outcomes for chronic-condition specialty therapies. Targeted at manufacturers and the patients enrolled in their therapies.
• National home delivery of medications Direct-to-patient home delivery of prescription and OTC medications across Mexico, with free shipping on qualifying orders, accessible via the demsaenlinea.mx e-commerce platform.
• Pharmacovigilance service (Farmacovigilancia) Drug safety monitoring and adverse event reporting service operated as part of the company's pharmaceutical-quality offering.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• NovartiscoreStrategic or Co-development PartnerNovartis participates in Demsa's patient adherence programs (Programas de Apego), providing support for patients using Novartis medications through the distribution network.
• RochecoreStrategic or Co-development PartnerRoche partners with Demsa through the Roche Por Ti adherence program, supporting patient access to Roche pharmaceutical products.
• SanoficoreStrategic or Co-development PartnerSanofi participates in Demsa's Entregando Salud (Delivering Health) adherence program, facilitating patient access to Sanofi's specialty medications.
• UCBcoreStrategic or Co-development PartnerUCB partners with Demsa through the 'Asi de Cerca' (This Close) adherence program, supporting patients using UCB medications.
• LillycoreStrategic or Co-development PartnerLilly participates in Demsa's Enlace Lilly adherence program, providing patient support and access to Lilly medications including Mounjaro, Trulicity, and other diabetes treatments.
• MerckcoreStrategic or Co-development PartnerMerck partners with Demsa in adherence programs supporting patient access to Merck's specialty pharmaceutical products.
• PfizercoreStrategic or Co-development PartnerPfizer partners with Demsa through the Pfizer Conmigo adherence program, supporting patients using Pfizer medications.
• AmgenminorStrategic or Co-development PartnerAmgen offers the REPATHA program for insurance patients through Demsa's adherence program platform.
• OrganonminorStrategic or Co-development PartnerOrganon products are distributed through Demsa's pharmacy network, including cardiovascular and other specialty medications.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Farmacia San Pablo: One of Mexico's largest specialty pharmacy chains with nationwide presence and an online store. Directly comparable to Demsa's hybrid retail + specialty + e-commerce model, though operating at meaningfully larger scale.
• Casa Saba: Major Mexican pharmaceutical distributor supplying hospitals, pharmacies, and government institutions. Most direct B2B distribution peer for the wholesale side of Demsa's business (per the firm's stated distribution to hospitals/government).
• Fármacos Nacionales: Mexican pharmaceutical distributor serving retail pharmacies and institutions. Comparable mid-scale distribution peer to Demsa's wholesale operations.
• Farmacia del Ahorro: Largest pharmacy chain in Mexico with thousands of locations and broad OTC/Rx mix. Comparable to Demsa as a direct retail pharmacy competitor, though focused more on volume/general meds vs Demsa's specialty tilt.
• Farmacia Guadalajara: Major Mexican pharmacy chain with strong specialty medication offering and national footprint, including a 24-hour location like Demsa. Direct competitor in retail specialty pharmacy segment.
• Benavides: Mexican pharmacy chain (part of FEMSA) with national presence and pharmacy/OTC mix. Direct retail pharmacy peer, though more general-OTC weighted versus Demsa's specialty focus.

Broad incumbents

• Nadro: One of the largest pharmaceutical distributors in Mexico, part of FEMSA's commercial division. Comparable as a broad incumbent in pharma distribution, though operating at substantially larger scale and serving institutional customers.
• Marzam: Major Mexican pharmaceutical wholesaler/distributor with broad Rx and OTC portfolio across the country. Comparable distribution-side peer operating at much greater scale.
• Walmart de México: Operates large pharmacy sections across its Bodega Aurrera, Walmart, and Sam's Club formats in Mexico. Broad incumbent retail competitor with pharmacy offering, though not specialty-focused.

Others

• Chedraui: Major Mexican retailer with in-store pharmacy sections across formats (Chedraui, Selecto Chedraui, Smart & Final). Adjacent competitor in the retail pharmacy space, though pharmacy is not their core focus.

Market position

Strengths2 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/demsa9404
• LinkedInlinkedin.com/company/53483290
• Instagraminstagram.com/demsamexico
• Xx.com/demsa3

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Demsa